Search - tctmd.com

Displaying 421 - 440 of 1211

Sort: Relevancy | Date

Presentation TCT 2017

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

Presenter: Fernando Alfonso, Jose P.S. Henriques

October 30, 2017

News Conference News TCT 2017

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Yael L. Maxwell

October 30, 2017

Presentation TCT 2017

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Presenter: Joseph P. Carrozza Jr, Jose M. Wiley, Binita Shah

October 29, 2017

News Industry News

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

September 19, 2017

News Features

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

Michael O'Riordan

September 13, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Conference News ESC 2017

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

Shelley Wood

August 30, 2017

News Daily News

Iliac Artery Occlusions Best Addressed by Self-Expanding Stents: ICE Trial

Caitlin E. Cox

August 25, 2017

Presentation CHIP Seattle 2017

Instent Restenosis

Presenter: Creighton W. Don

August 11, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

Presentation

Incidence, Procedural Management, and Clinical Outcomes of Coronary In-stent Restenosis

July 19, 2017

News Daily News

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

L.A. McKeown

July 18, 2017

News Daily News

TAVR Deterioration Rare Over 5 Years: Meta-analysis

Caitlin E. Cox

July 12, 2017

News Daily News

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

Yael L. Maxwell

June 30, 2017

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Featured Fellow

Ankur Kalra, MD

Yael L. Maxwell

May 26, 2017

News Conference News EuroPCR 2017

Slimmest Stent to Date Looks Promising in Small Study

Shelley Wood

May 19, 2017

News Industry News

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

May 18, 2017

Advertisement

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

DARE: A Randomized Trial of a Drug-Eluting Balloon vs a Metallic DES in Patients With Coronary Artery In-Stent Restenosis

Compared With Provisional Stenting, Double-Kissing Crush Technique Reduces Left Main Disease Events at 1 Year

Drug-Eluting Stent Thrombosis and Restenosis: Mechanisms, Frequency, and Treatment

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

Absorb Vanishes, but Can Other Bioresorbable Scaffolds Make Magic Happen?

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

Iliac Artery Occlusions Best Addressed by Self-Expanding Stents: ICE Trial

Instent Restenosis

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Incidence, Procedural Management, and Clinical Outcomes of Coronary In-stent Restenosis

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

TAVR Deterioration Rare Over 5 Years: Meta-analysis

Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Ankur Kalra, MD

Slimmest Stent to Date Looks Promising in Small Study

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content